EU regulators move up Pfizer vaccine assessment to December 21

The European Union’s medicines agency says it has moved up a meeting to assess the Pfizer-BioNTech coronavirus vaccine for provisional approval in the 27-nation bloc to December 21.

The agency says it made the decision after receiving additional data from the vaccine makers.

The announcement comes after Germany’s health minister and others publicly demanded that the agency move quicker than its previously planned December 29 meeting at which it was to discuss approving the vaccine.

The vaccine is already being given to thousands of people in Britain, Canada and the United States.

— AP